Navigation Links
InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
Date:11/19/2008

Stem cell culture innovator asks the regenerative medicine community: "Are Your Cells Free?" Learn more about InVitria at TERMIS North America 2008, Dec. 7-10 in San Diego, CA.

Fort Collins, CO (PRWEB) November 19, 2008 -- Stem cell culture researchers and the regenerative medicine community are meeting at the 2008 North American Tissue Engineering Meeting TERMIS in San Diego on Dec. 7-10. They will have the chance to learn how InVitria's product line can make their cells "Be Free" of animal components by using defined cell culture media supplements, while also receiving a complimentary InVitria "BE FREE" t-shirt.

InVitria's Cellastim Cellastim a recombinant albumin is an animal free and defined cell culture media supplement. Cellastim has been shown to outperform animal derived albumins such as human serum albumin and bovine serum albumin. In addition, InVitria's Lacromin Lacromin a recombinant lactoferrin is an animal free growth factor that improves cell viability in long-term culture.

"We are excited to attend this premier annual event for the tissue engineering community," said Brandy Sargent, InVitria's Sales Manager. "TERMIS is a great venue for InVitria to share its successes, while also learning from an exceptionally talented group of individuals the discoveries, applications and products for stem cell and regenerative medicine."

"Stem cell media and regenerative medicine are exciting applications for the products we have developed," said Dr. Ning Huang, InVitria's VP of Resear
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

1

GOOD

Page: 1 2

Related medicine news :

1. InVitria to Present at WilBio's International Cell Engineering Meeting
2. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
3. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
4. UPMC Health Plan Launches New Personal Health Record
5. HealthInsuranceFinders.com Launches Video Contest for Young Directors
6. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
7. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
8. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
9. Mannatech Launches Phase One of New Sales and Training Tools
10. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
11. Actavis Launches Carvedilol Tablets in the U.S.

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
(Date:11/27/2009)...27 Shamir Optical Indust...rovider of innovative products and technology to t...s board of directors had declared a dividend distr...approximately NIS 37.62 million based on the Novem...approximately US$ 0.609 (approximately NIS 2.3 bas...
(Date:11/27/2009)...ical, economic burdens, study predicts , ...of people with diabetes in the United States is ex...dy predicts. , That would bring the total by 20...up from 23.7 million today. , , At the same time...riple, the study also warns, rising from an estima...
(Date:11/27/2009)...bilingual coloring books designed for children age...ity to educate - inform parents and children alike...nosuars to ABC,S and a host of other topics. , ...mber 27, 2009 -- Today’s children have enoug...ny hour of the day, but one of the oldest and simp...
(Date:11/26/2009)...e/ -- With cold and flu season upon us, it,s more ...ntrol the spread of infections and avoid illness. ...rselves healthy, but to avoid transmitting illness...(certified in infection-control), nursing director...Hospital for Special Surgery (HSS) in Manhattan. ,...
(Date:11/26/2009)...molybdate (TM) has been shown in studies to be eff...se caused by an overload of copper, and certain me... however, is known about how the drug works at the...ern University researchers now has provided an inv...M bound to copper-loaded metallochaperones. The dr...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...d that DDT can cause developmental delays in infan... While DDT is currently banned in the United Sta... combat mosquitoes that spread malaria. Accordi... benefits of DDT use to reduce malaria must be con...
...tish tourists face several health risks are riskin... anti malaria pills before they go abroad//. T...ople have visited tropical countries on holiday ov...r cent of British tourists who have visited count...
...sters to approve a progress report on a national p...nancial// help of the federal government to cover ... in Fredericton was planned to be conducted withou...dication of help to pay for the initiative. Acc...
... and scientist are still doing exhaustive research...ope to millions of sick and disabled people that t...world's first clone of an adult mammal. From then ...bryonic stem cell branched out, or differentiated,...
...olved in tumor-suppression or cell-proliferation-s...of pancreatic islet cells, which again affected bl...sity of Pennsylvania School of Medicine reports. ...plications for diabetes treatment. MEN1 patien...
...ith psychological problems into adulthood. A new s...lity of life can be used to learn about the psycho...ntion and treatment. Oral clefting is one o...n experience challenging psychological adjustment ...
Other Medicine News:Health News:Developmental Delays in Infants Linked to DDT 2Health News:Tourists Face Health Risks by Missing Vaccinations 2Health News:Clement Urged to Plot a National Pharmaceutical Strategy 2Health News:Dolly Paves the Way for Exhaustive Stem Cell Research 2Health News:Menin Gene Mutation made Insulin Secreting Cells to Proliferate 2Health News:Learning the Value of Prevention and Treatment in Oral Clefting 2
(Date:11/29/2009)...swire/ -- Royal Philips Electronics ( PHG, AEX: PH...d by showing its portfolio of products designed to...meeting of the Radiological Society of North Ameri...are several advancements and upgrades focused on r...eamlining workflow to expand upon clinical capabil...
(Date:11/29/2009)...wire/ -- FUJIFILM Medical Systems USA, Inc., the w...M) with over 7,000 installations, is pleased to de...in the US. The Aspire HD combines the use of adva...eration detector technology and the smallest pixel...solution at a reduced dose for the patient. The f...
(Date:11/29/2009)...e/ -- Researchers using functional magnetic resona...found that men and women respond differently to po...presented today at the annual meeting of the Radio...n may direct more attention to sensory aspects of ...s of implications for required action, whereas wom...
Breaking Medicine Technology:Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 1Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 2BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 1BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 2BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 3Georgia State researcher to use 241 million grant to improve computer models for fighting wildfires 10045 1Georgia State researcher to use 241 million grant to improve computer models for fighting wildfires 10045 2
...nificant Anti-Tumor Effects of Targeted, Systemic,...n the Limits of,Safe Administrations in Rodent and...007 /PRNewswire/ -- Calando,Pharmaceuticals, a lea...ed subsidiary of Arrowhead Research Corporation,pr...esting in mice,using multiple, systemic dosing wit...
...lif.--(BUSINESS WIRE)--Apr 16, 2007 - Amgen,(Nasda...zed,double-blind, placebo-controlled Phase 3 stud... (darbepoetin alfa) for the,treatment of anemia in...erapy or radiotherapy ("the 103 study"). Aranesp i... patients. These,results were presented in an oral...
Other Medicine Technology:Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 2Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 3Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7
Force EZ Electrosurgical Generator
Black Multi-Pinhole Occluder
49 Pinhole short handle
Frosted Long Handle Occluder
Medicine Products: